SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042612
Filing Date
2021-08-09
Accepted
2021-08-09 16:04:36
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 Q3 2021 10-Q enta-10q_20210630.htm   iXBRL 10-Q 2643984
2 EX-31.1 enta-ex311_8.htm EX-31.1 16042
3 EX-31.2 enta-ex312_6.htm EX-31.2 16028
4 EX-32.1 enta-ex321_7.htm EX-32.1 8767
5 GRAPHIC gzj0vhanuiyy000001.jpg GRAPHIC 112292
  Complete submission text file 0001564590-21-042612.txt   8389651

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20210630.xsd EX-101.SCH 33775
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20210630_cal.xml EX-101.CAL 45352
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20210630_def.xml EX-101.DEF 101600
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20210630_lab.xml EX-101.LAB 302143
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20210630_pre.xml EX-101.PRE 245139
11 EXTRACTED XBRL INSTANCE DOCUMENT enta-10q_20210630_htm.xml XML 1703308
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 211156416
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences